Zika virus Tdap vacciene cover up

Is it the dTap purtusis vaccines administered at 22 weeks of pregnancy or the GM Mosquitoes recently released that are causing the birth defect seen in theses poor baby’s?

http://yournewswire.com/is-zika-viru…cts-in-brazil/

The Zika virus has been known to infect people in Africa, South and Central America and Asia for more than 70 years without causing any birth defects.

The Brazilian government declared an emergency in December after 2,400 babies were found to be born with shrunken heads and brain defects believed to be linked to mosquitoes carrying the Zika Virus. The number of babies born with the defects has been rising significantly since then.

But could there be a link between the introduction of the Tdap vaccination that women in Latin America were urged to get before they were 22 weeks pregnant, and the birth of babies with these deformities called “Microcephaly” (literally ‘tiny head’)?

The following is an article from Brazilian shrunken head babies blog:

In late 2014, the Ministry of Health of Brazil announced the introduction of the Tdap (Tetanus, diphtheria, and acellular pertussis) vaccine for all pregnant women in that country as part of its routine vaccination program. The move was aimed at trying to contain the resurgence of pertussis in Brazil.

In December 2015, the Brazilian government declared an emergency after 2,400 Brazilian babies were found to be born with shrunken heads (microcephaly) and damaged brains since October.

Brazilian public health officials don’t know what is causing the increase in microcephaly cases in babies born in Brazil, but they are theorizing that it may be caused by a virus known as “Zika,” which is spread by mosquitoes (Aedes aegypti)—in the same way as is the West Nile virus.

this is the result:

The theory is largely based on the fact that they found the Zika virus in a baby with microcephaly following an autopsy of the dead child. The virus was also found in the amniotic fluid of two mothers whose babies had the condition.

Note that Zika is not a new virus; it has been around for decades. No explanation has been given as to why suddenly it could be causing all these cases of microcephaly. No one is seriously asking the question, “What has changed?”

There is no theorizing about the possibility that the cases of microcephaly could be linked to the mandating of the Tdap vaccine for all pregnant women in Brazil about 10 months earlier. The government has “assumed” the cause is a virus.

FACT—Drug companies did not test the safety and effectiveness of giving Tdap vaccine to pregnant women before the vaccines were licensed in the U.S. and there is almost no data on inflammatory or other biological responses to this vaccine that could affect pregnancy and birth outcomes.

FACT—According to the U.S. Food and Drug Administration (FDA) adequate testing has not been done in humans to demonstrate safety for pregnant women and it is not known whether the vaccines can cause fetal harm or affect reproduction capacity. The manufacturers of the Tdap vaccine state that human toxicity and fertility studies are inadequate and warn that Tdap should “be given to a pregnant woman only if clearly needed.”

FACT—There are ingredients pertussis containing Tdap vaccine that have not been fully evaluated for potential genotoxic or other adverse effects on the human fetus developing in the womb that may negatively affect health after birth, including aluminum adjuvants, mercury containing (Thimerosal) preservatives and many more bioactive and potentially toxic ingredients.

FACT—There are serious problems with outdated testing procedures for determining the potency and toxicity of pertussis vaccines and some scientists are calling for limits to be established for specific toxin content of pertussis-containing vaccines.

FACT—There are no published biological mechanism studies that assess pre-vaccination health status and measure changes in brain and immune function and chromosomal integrity after vaccination of pregnant women or their babies developing in the womb.

FACT—Since licensure of Tdap vaccine in the U.S., there have been no well designed prospective case controlled studies comparing the health outcomes of large groups of women who get pertussis containing Tdap vaccine during pregnancy either separately or simultaneously compared to those who do not get the vaccines, and no similar health outcome comparisons of their newborns at birth or in the first year of life have been conducted. Safety and effectiveness evaluations that have been conducted are either small, retrospective, compare vaccinated women to vaccinated women or have been performed by drug company or government health officials using unpublished data.

FACT—FACT—The FDA has licensed Tdap vaccines to be given once as a single dose pertussis booster shot to individuals over 10 or 11 years old. The CDC’s recommendation that doctors give every pregnant woman a Tdap vaccination during every pregnancy—regardless of whether a woman has already received one dose of Tdap—is an off-label use of the vaccine.

                   *note  “Administer Tdap to women during each pregnancy regardless of previous Tdap vaccination history.” 

           
FACT—Injuries and deaths from pertussis-containing vaccines are the most compensated claims in the federal Vaccine Injury Compensation Program (VICP) and influenza vaccine injuries and deaths are the second most compensated claim.

FACT—A 2013 published study evaluating reports of acute disseminated encephalomyelitis (ADEM) following vaccination in the U. S. Vaccine Adverse Events Reporting System (VAERS) and in a European vaccine reaction reporting system found that pertussis containing DTaP was among the vaccines most frequently associated with brain inflammation in children between birth and age five.

Tdap is manufactured by two pharmaceutical companies: Sanofi Pasteur of France and GlaxoSmithKline (GSK) of the United Kingdom.

The Sanofi Pasteur product contains aluminum phosphate, residual formaldehyde, residual glutaraldehyde, and 2-phenoxyethanola, along with the following growth mediums and process ingredients: Stainer-Scholte medium, casamino acids, dimethyl-beta-cyclodextrin, glutaraldehyde, formaldehyde, aluminum phosphate, modified Mueller-Miller casamino acid medium without beef heart infusion, ammonium sulfate, 2-phenoxyethanol, water for injection.

The GSK product contains aluminum hydroxide, sodium chloride, residual formaldehyde, polysorbate 80 (Tween 80), along with the following growth mediums and process ingredients: modified Latham medium derived from bovine casein, Fenton medium containing bovine extract, formaldehyde, Stainer-Scholte liquid medium, glutaraldehyde, aluminum hydroxide.

Unsurprisingly, the Brazilian government announced on January 15, 2016 it will direct funds to a biomedical research center (Sao Paulo-based Butantan Institute) to help develop a vaccine against Zika. Development of the vaccine is expected to take 3-5 years. Again, no consideration to the irony that you may be developing a vaccine to address a problem that may have been CAUSED by a vaccine, and that that new vaccine may COMPOUND the problem No consideration to the possibility that the answer to the problem may not be to do MORE, but rather to do LESS (simply STOP giving Tdap to pregnant women).

The number of cases of microcephaly in Brazil has grown to 3,530 babies, as of mid-January 2016. Fewer than 150 such cases were seen in all of 2014.

Has this vaccine been used in the US in that time period? If it had, you would see a lot more problems there as well. Is it Zika, something else, a combination? Scary situation all around.

 

http://www.healthnutnews.com/breakin…released-2015/

Breaking: Zika Outbreak Epicenter in Same Area Where GM Mosquitoes Were Released in 2015
January 29, 2016
(ANTIMEDIA) U.S.A. — The World Health Organization announced it will convene an Emergency Committee under International Health Regulations on Monday, February 1, concerning the Zika virus ‘explosive’ spread throughout the Americas. The virus reportedly has the potential to reach pandemic proportions — possibly around the globe. But understandingwhy this outbreak happened is vital to curbing it. As the WHOstatement said:

“A causal relationship between Zika virus infection and birth malformations and neurological syndromes … is strongly suspected. [These links] have rapidly changed the risk profile of Zika, from a mild threat to one of alarming proportions.

“WHO is (apparently) deeply concerned about this rapidly evolving situation for 4 main reasons: the possible association of infection with birth malformations and neurological syndromes; the potential for further international spread given the wide geographical distribution of the mosquito vector; the lack of population immunity in newly affected areas; and the absence of vaccines, specific treatments, and rapid diagnostic tests […]

“The level of concern is high, as is the level of uncertainty.”

Zika seemingly exploded out of nowhere. Though it was first discovered in 1947, cases only sporadically occurred throughout Africa and southern Asia. In 2007, the first case was reported in the Pacific. In 2013, a smattering of small outbreaks and individual cases were officially documented in Africa and the western Pacific. They also began showing up in the Americas. In May 2015, Brazil reported its first case of Zika virus — and the situation changed dramatically.

Brazil is now considered the epicenter of the Zika outbreak, which coincides with at least 4,000 reports of babies born with microcephaly just since October.

When examining a rapidly expanding potential pandemic, it’s necessary to leave no stone unturned so possible solutions, as well as future prevention, will be as effective as possible. In that vein, there was another significant development in 2015.

Oxitec first unveiled its large-scale, genetically-modified mosquito farm in Brazil in July 2012, with the goal of reducing “the incidence of dengue fever,” as The Disease Daily reported. Dengue fever is spread by the same Aedes mosquitoes which spread the Zika virus — and though they “cannot fly more than 400 meters,” WHO stated, “it may inadvertently be transported by humans from one place to another.” By July 2015, shortly after the GM mosquitoes were first released into the wild in Juazeiro, Brazil, Oxitec proudly announced they had “successfully controlled the Aedes aegypti mosquito that spreads dengue fever, chikungunya and zika virus, by reducing the target population by more than 90%.”

Though that might sound like an astounding success — and, arguably, it was — there is an alarming possibility to consider.

Nature, as one Redditor keenly pointed out, finds a way — and the effort to control dengue, zika, and other viruses, appears to have backfired dramatically.

Map showing the concentration of suspected Zika-related cases of microcephaly in Brazil.

The particular strain of Oxitec GM mosquitoes, OX513A, are genetically altered so the vast majority of their offspring will die before they mature — though Dr. Ricarda Steinbrecher published concerns in a report in September 2010 that a known survival rate of 3-4 percent warranted further study before the release of the GM insects. Her concerns, which were echoed by several other scientists both at the time and since, appear to have been ignored — though they should not have been.

Those genetically-modified mosquitoes work to control wild, potentially disease-carrying populations in a very specific manner. Only the male modified Aedes mosquitoes are supposed to be released into the wild — as they will mate with their unaltered female counterparts. Once offspring are produced, the modified, scientific facet is supposed to ‘kick in’ and kill that larvae before it reaches breeding age — if tetracycline is not present during its development. But there is a problem.

zika-mosquito

Aedes aegypti mosquito. Image credit: Muhammad Mahdi Karim
According to an unclassified document from the Trade and Agriculture Directorate Committee for Agriculture dated February 2015, Brazil is the third largest in “global antimicrobial consumption in food animal production” — meaning, Brazil is third in the world for its use of tetracycline in its food animals. As a study by the American Society of Agronomy, et. al., explained, “It is estimated that approximately 75% of antibiotics are not absorbed by animals and are excreted in waste.” One of the antibiotics (or antimicrobials) specifically named in that report for its environmental persistence is tetracycline.

In fact, as a confidential internal Oxitec document divulged in 2012, that survival rate could be as high as 15% — even with low levels of tetracycline present. “Even small amounts of tetracycline can repress” the engineered lethality. Indeed, that 15% survival rate was described by Oxitec:

“After a lot of testing and comparing experimental design, it was found that [researchers] had used a cat food to feed the [OX513A] larvae and this cat food contained chicken. It is known that tetracycline is routinely used to prevent infections in chickens, especially in the cheap, mass produced, chicken used for animal food. The chicken is heat-treated before being used, but this does not remove all the tetracycline. This meant that a small amount of tetracycline was being added from the food to the larvae and repressing the [designed] lethal system.”

Even absent this tetracycline, as Steinbrecher explained, a “sub-population” of genetically-modified Aedes mosquitoes could theoretically develop and thrive, in theory, “capable of surviving and flourishing despite any further” releases of ‘pure’ GM mosquitoes which still have that gene intact. She added, “the effectiveness of the system also depends on the [genetically-designed] late onset of the lethality. If the time of onset is altered due to environmental conditions … then a 3-4% [survival rate] represents a much bigger problem…”

As the WHO stated in its press release, “conditions associated with this year’s El Nino weather pattern are expected to increase mosquito populations greatly in many areas.”

Incidentally, President Obama called for a massive research effort to develop a vaccine for the Zika virus, as one does not currently exist. Brazil has now called in 200,000 soldiers to somehow help combat the virus’ spread. Aedes mosquitoes have reportedly been spotted in the U.K. But perhaps the most ironic — or not —proposition was proffered on January 19, by the MIT Technology Review:

“An outbreak in the Western Hemisphere could give countries including the United States new reasons to try wiping out mosquitoes with genetic engineering.

“Yesterday, the Brazilian city of Piracicaba said it would expand the use of genetically modified mosquitoes …

“The GM mosquitoes were created by Oxitec, a British company recently purchased by Intrexon, a synthetic biology company based in Maryland. The company said it has released bugs in parts of Brazil and the Cayman Islands to battle dengue fever.”
 

http://www.healthnutnews.com/breakin…released-2015/

“so the vast majority of their offspring will die before they mature …”

Hmmm—-

so…..

is it a “leap” of logic to think the SAME effect might happen with “other” offspring, not just the mosquitoes’ —- and cause THAT offspring to actually NOT “mature”—-as in arrested development of the brain / head?

Shades of Thalidomide and the karma of “unintended consequences”….